
    
      Primary Objective: To estimate overall survival and quality of life.

      Secondary Objectives

        -  To estimate progression-free survival

        -  To evaluate safety and tolerability in this patient population.

        -  To evaluate the effect on levels of alpha-fetoprotein.
    
  